Frank C. Sparks

1.8k total citations
30 papers, 1.4k citations indexed

About

Frank C. Sparks is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Frank C. Sparks has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Frank C. Sparks's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Frank C. Sparks is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Frank C. Sparks collaborates with scholars based in United States. Frank C. Sparks's co-authors include Donald L. Morton, Frederick R. Eilber, Beth E. Meyerowitz, Melvin J. Silverstein, John S. Hunt, E. Carmack Holmes, Alfred S. Ketcham, Kenneth P. Ramming, Yosef H. Pilch and Charles M. Haskell and has published in prestigious journals such as New England Journal of Medicine, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Frank C. Sparks

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank C. Sparks United States 16 793 533 295 185 177 30 1.4k
Daniel E. Lehane United States 21 596 0.8× 221 0.4× 184 0.6× 277 1.5× 195 1.1× 51 1.6k
Derek Crowther United Kingdom 21 592 0.7× 210 0.4× 96 0.3× 185 1.0× 280 1.6× 55 1.4k
Joel M. Rappeport United States 26 293 0.4× 913 1.7× 130 0.4× 106 0.6× 208 1.2× 49 2.1k
Patrick G. Beatty United States 24 673 0.8× 1.6k 3.1× 208 0.7× 117 0.6× 193 1.1× 44 3.5k
Soji F. Oluwole United States 24 592 0.7× 746 1.4× 555 1.9× 123 0.7× 208 1.2× 127 2.2k
WE Fibbe Netherlands 24 498 0.6× 759 1.4× 54 0.2× 169 0.9× 257 1.5× 36 1.9k
Claire Galambrun France 29 395 0.5× 494 0.9× 151 0.5× 127 0.7× 312 1.8× 79 2.5k
Anne Angiolillo United States 22 915 1.2× 814 1.5× 80 0.3× 192 1.0× 523 3.0× 76 2.7k
Hisao Takizawa Japan 23 178 0.2× 975 1.8× 369 1.3× 73 0.4× 317 1.8× 82 1.9k
Adrienne Morgan United Kingdom 19 282 0.4× 260 0.5× 64 0.2× 174 0.9× 247 1.4× 48 1.2k

Countries citing papers authored by Frank C. Sparks

Since Specialization
Citations

This map shows the geographic impact of Frank C. Sparks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank C. Sparks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank C. Sparks more than expected).

Fields of papers citing papers by Frank C. Sparks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank C. Sparks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank C. Sparks. The network helps show where Frank C. Sparks may publish in the future.

Co-authorship network of co-authors of Frank C. Sparks

This figure shows the co-authorship network connecting the top 25 collaborators of Frank C. Sparks. A scholar is included among the top collaborators of Frank C. Sparks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank C. Sparks. Frank C. Sparks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giuliano, Armando E., et al.. (1986). Adjuvant chemo‐lmmunotherapy in stage II carcinoma of the breast. Journal of Surgical Oncology. 31(4). 255–259. 11 indexed citations
2.
Meyerowitz, Beth E., et al.. (1983). Psychosocial implications of adjuvant chemotherapy. A two-year follow-up. Cancer. 52(8). 1541–1545. 46 indexed citations
3.
Sparks, Frank C.. (1982). Embolization of Bleeding Esophageal Varices via Umbilical Vein. Archives of Surgery. 117(3). 354–354. 3 indexed citations
4.
Meyerowitz, Beth E., et al.. (1979). Adjuvant chemotherapy for breast carcinoma:Psychosocial implications. Cancer. 43(5). 1613–1618. 138 indexed citations
5.
Sparks, Frank C., et al.. (1979). Pancreatic ascites: Management by caudal pancreatectomy and side-to-side pancreaticojejunostomy. The American Journal of Surgery. 138(5). 713–715. 2 indexed citations
6.
Sparks, Frank C., et al.. (1978). Breast cancer presenting as renal colic. The American Journal of Surgery. 135(6). 842–845. 7 indexed citations
7.
Wile, Alan G., Frank C. Sparks, & Donald L. Morton. (1977). Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.. PubMed. 37(7 Pt 1). 2251–6. 11 indexed citations
8.
9.
Storm, F. Kristian, et al.. (1977). A prospective study of parotid metastases from head and neck cancer. The American Journal of Surgery. 134(1). 115–119. 56 indexed citations
10.
Lee, Yeu‐Tsu N., Frank C. Sparks, & Donald L. Morton. (1977). Primary Melanoma of Skin of the Breast Region. Annals of Surgery. 185(1). 17–22. 14 indexed citations
11.
Morton, Donald L., Frederick R. Eilber, E. Carmack Holmes, Frank C. Sparks, & Kenneth P. Ramming. (1976). BCG Immunotherapy as a Systemic Adjunct to Surgery in Malignant Melanoma. Medical Clinics of North America. 60(3). 431–439. 12 indexed citations
12.
Ramming, Kenneth P., et al.. (1976). Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma. The American Journal of Surgery. 132(2). 236–242. 48 indexed citations
13.
Pilch, Yosef H., George H. Myers, Frank C. Sparks, & Sidney H. Golub. (1975). Prospects for the immunotherapy of cancer. Current Problems in Surgery. 12(2). 1–61. 9 indexed citations
14.
Sparks, Frank C., et al.. (1975). Generalized Cutaneous Reaction Associated with the Intratumor Injection of BCG. CHEST Journal. 68(5). 725–727. 13 indexed citations
15.
Sparks, Frank C., Michael B. Mosher, Melvin J. Silverstein, et al.. (1975). Hepatic artery ligation and postoperative chemotherapy for hepatic metastases: Clinical and pathophysiological results. Cancer. 35(4). 1074–1082. 50 indexed citations
16.
Morton, Donald L., Frederick R. Eilber, E. Carmack Holmes, et al.. (1974). BCG lmmunotherapy of Malignant Melanoma. Annals of Surgery. 180(4). 635–643. 333 indexed citations
17.
Haskell, Charles M., Melvin J. Silverstein, Decio M. Rangel, et al.. (1974). Multimodality cancer therapy in man: A pilot study of adriamycin by arterial infusion. Cancer. 33(6). 1485–1490. 28 indexed citations
18.
Sparks, Frank C. & James Breeding. (1974). Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.. PubMed. 34(12). 3262–9. 36 indexed citations
19.
Sparks, Frank C., et al.. (1974). Axillo-Mesenteric Bypass for Acute Mesenteric Infarction. Vascular Surgery. 8(2). 90–94. 8 indexed citations
20.
Sparks, Frank C., Melvin J. Silverstein, John S. Hunt, et al.. (1973). Complications of BCG Immunotherapy in Patients with Cancer. New England Journal of Medicine. 289(16). 827–830. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026